Ex-Trump Aide’s ‘Inspire Hope’ Virus Ads Face Scrutiny From HHS
(Bloomberg) -- A controversial $300 million ad campaign about the coronavirus being developed by the U.S. Department of Health and Human Services will face a “strategic review,” the department's leader said.
The media campaign, funded by the U.S. Centers for Disease Control and Prevention, has been a source of controversy for more than a month, since Politico reported it was designed to “defeat despair and inspire hope” in messages potentially landing around the election.
The ads were conceived by Michael Caputo, a former campaign aide to President Donald Trump and top public affairs official at HHS, who has since taken medical leave. Any products from the campaign will be “reviewed by career public health officials,” including those at the CDC, HHS Secretary Alex Azar told members of congress in a hearing Friday.
The ad campaign is the only notable initiative to be funded out of $1 billion in emergency funds congress sent the CDC in April, Bloomberg News reported Thursday. CDC director Robert Redfield has testified that the agency had no involvement in the campaign other than financially supporting it. The rest of the $1 billion remains unspent, despite CDC's requests to access it.
Azar disclosed the review of the campaign during a wide-ranging hearing by the House Select Subcommittee on the Coronavirus Crisis. He defended the administration response to the pandemic after Democrats on the committee alleged political interference in scientific agencies, including the CDC and the Food and Drug Administration, which will vet vaccines now in trials.
Azar said the strategic review would seek “to determine whether the campaign serves important public health purposes.”
But even as Azar said HHS would review the messaging campaign, he defended its purpose. “This is important public health messaging,” he said, comparing the cost to other federal health advertising around quitting smoking or enrolling in health insurance.
Republican members on the panel, meanwhile, sought to place blame for the growth of coronavirus in the U.S. on China and accused some Democratic governors of exacerbating the crisis and sowing doubt about vaccine safety.
Azar also fielded questions from Democratic members about the Affordable Care Act, which the Trump administration is asking the Supreme Court to invalidate in a case that will be argued a week after Election Day.
Azar said Obamacare was an option for millions of people who lost health coverage during the pandemic, while also noting that policies can be costly for those without subsidies. If the court strikes the law, Azar said, “we will work with congress to replace it with real health care.”
©2020 Bloomberg L.P.
-
'Never Seen This Level Of Negativity': Sandeep Tandon Says The Next Rally May Be Closer Than You Think
Veteran investor Sandeep Tandon says foreign selling is easing, large-caps are due a comeback and mid-caps are crowded, while he turns positive on gold, power and pharma this Diwali.
-
Indians Stay With Family, Not In Hotels | The Reason Why
India still lacks enough clean, reliable and affordable hotels for budget-conscious travellers.
-
The Economic Imperative: Analysing The Material Driving Force Behind India-Canada Strategic Reset
This economic complementarity is further reinforced by deep institutional investment ties and talent mobility, which form the bedrock of the bilateral framework.
-
Medicine Pricing: Where Must Profit Stop?
India must confront excessive margins, hidden incentives and regulatory gaps that threaten the integrity of medicine.
-
Why Amazon And Flipkart Are Struggling To Beat Meesho In India's Smaller Cities
With 274 million users and lowest-cost logistics, Meesho is defending its value commerce crown against giants like Amazon and Flipkart.
-
High US Salaries, No Green Card Certainty: The Financial Calculation Facing Indian H-1B Families
The suspension of PERM processing at eight technology employers does not cancel existing H-1B visas. What it does is force a question many Indian families have been avoiding: is the US salary worth tying your career and family plans to one employer?
-
Swiggy vs Eternal: Food Delivery's Two Rivals Are No Longer In The Same Race
Eternal is building a private AI assistant, dark.ai. Swiggy is still working out how to make Instamart pay, with an operating loss of Rs 895 crore in the July-September quarter while Blinkit stayed profitable.
-
Where You Live Shapes How You Get To Work | The Reason Why
Two-wheelers are the most popular way to get to work in India, accounting for nearly 43% of workplace commutes.
-
Unhedged Position: Can India See An Indonesia-Style Time Correction?
The Nifty is trading below levels it first clocked in 2024. Is there, then, as I have suggested in the headline, potential that the current time correction drags on painfully for the next three-five, even ten years?
-
Navigating Friction And Energy Realities: An Analysis Of Marco Rubio's October Visit To India
Occurring at a critical juncture marked by stalled trade negotiations and escalating geopolitical pressures over global energy supplies, the visit offers a profound window into modern US-India relations.